Immune-mediated mechanisms of action of probiotics and synbiotics in treating pediatric intestinal diseases

Nutrients

Volumn 10, Issue 1, 2018, Pages

  Plaza Díaz, Julio ^a,b   Ruiz Ojeda, Francisco Javier ^a,b   Gil Campos, Mercedes ^c,d   Gil, Angel ^a,b,c  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Immune system; Intestinal microbiota; Mechanism of action; Pediatric gastrointestinal infection; Probiotics

Indexed keywords

PROBIOTIC AGENT; SYNBIOTIC AGENT; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA;

ACUTE GASTROENTERITIS; CLOSTRIDIUM DIFFICILE INFECTION; CYSTIC FIBROSIS; DENDRITIC CELL; DIARRHEA; ENTEROPATHY; GASTROINTESTINAL INFECTION; HELICOBACTER INFECTION; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SALIVARIUS; NECROTIZING ENTEROCOLITIS; PEPTIC ULCER; REVIEW; VOMITING; AGE; BACTERIUM; CHILD; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INFANT; INTESTINE; INTESTINE FLORA; MICROBIOLOGY; PRESCHOOL CHILD; TREATMENT OUTCOME;

AGE FACTORS; BACTERIA; CHILD; CHILD, PRESCHOOL; GASTROINTESTINAL MICROBIOME; HOST-PATHOGEN INTERACTIONS; HUMANS; INFANT; INTESTINAL DISEASES; INTESTINES; PROBIOTICS; SYNBIOTICS; TREATMENT OUTCOME;

EID: 85040605697     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu10010042     Document Type: Review

References (91)

1. Kvaerner, K.J.; Nafstad, P.; Jaakkola, J.J. Upper respiratory morbidity in preschool children: A cross-sectional study. Arch. Otolaryngol. Head Neck Surg. 2000, 126, 1201–1206. [CrossRef] [PubMed]
2. Lu, N.; Samuels, M.E.; Shi, L.; Baker, S.L.; Glover, S.H.; Sanders, J.M. Child day care risks of common infectious diseases revisited. Child Care Health Dev. 2004, 30, 361–368. [CrossRef] [PubMed]
3. Laursen, R.P.; Larnkjær, A.; Ritz, C.; Hauger, H.; Michaelsen, K.F.; Mølgaard, C. Probiotics and child care absence due to infections: A randomized controlled trial. Pediatrics 2017, 140, e20170735. [CrossRef] [PubMed]
4. Nafstad, P.; Hagen, J.A.; Oie, L.; Magnus, P.; Jaakkola, J.J.K. Day care centers and respiratory health. Pediatrics 1999, 103, 753–758. [CrossRef] [PubMed]
5. Pickering, L.K.; Bartlett, A.V.; Woodward, W.E. Acute infectious diarrhea in day care: Epidemiology and control. Rev. Infect. Dis 1986, 8, 539–547. [CrossRef] [PubMed]
6. Binsztein, N.; Picandet, A.M.; Notario, R.; Patrito, E.; De Lesa, M.E.; De Petris, A.; Maurel, D.; Nader, O.; Rivas, M.; Szefner, M.; et al. Antimicrobial resistance among species of Salmonella, Shigella, Escherichia, and Aeromonas isolated from children with diarrhea in 7 Argentinian centers. Rev. Latinoam. Microbiol. 1999, 41, 121–126. [PubMed]
7. Hudson, L.E.; Anderson, S.E.; Corbett, A.H.; Lamb, T.J. Gleaning insights from fecal microbiota transplantation and probiotic studies for the rational design of combination microbial therapies. Clin. Microbiol. Rev. 2017, 30, 191–231. [CrossRef] [PubMed]
8. Esposito, S.; Umbrello, G.; Castellazzi, L.; Principi, N. Treatment of Clostridium difficile infection in pediatric patients. Expert Rev. Gastroenterol. Hepatol. 2015, 9, 747–755. [CrossRef] [PubMed]
9. Pacifico, L.; Osborn, J.F.; Bonci, E.; Romaggioli, S.; Baldini, R.; Chiesa, C. Probiotics for the treatment of Helicobacter pylori infection in children. World J. Gastroenterol. 2014, 20, 673–683. [CrossRef] [PubMed]
10. Soriano-Gabarró, M.; Mrukowicz, J.; Vesikari, T.; Verstraeten, T. Burden of rotavirus disease in European Union countries. Pediatr. Infect. Dis. J. 2006, 25, S7–S11. [CrossRef] [PubMed]
11. Thielman, N.M.; Guerrant, R.L. Clinical practice. Acute infectious diarrhea. N. Engl. J. Med. 2004, 350, 38–47. [CrossRef] [PubMed]
12. Vandenplas, Y.; De Greef, E.; Devreker, T.; Veereman-Wauters, G.; Hauser, B. Probiotics and prebiotics in infants and children. Curr. Infect. Dis. Rep. 2013, 15, 251–262. [CrossRef] [PubMed]
13. Szajewska, H.; Dziechciarz, P. Gastrointestinal infections in the pediatric population. Curr. Opin. Gastroenterol. 2010, 26, 36–44. [CrossRef] [PubMed]
14. Caffarelli, C.; Cardinale, F.; Povesi-Dascola, C.; Dodi, I.; Mastrorilli, V.; Ricci, G. Use of probiotics in pediatric infectious diseases. Expert Rev. Anti-Infect. Ther. 2015, 13, 1517–1535. [CrossRef] [PubMed]
15. Plaza-Díaz, J.; Ruiz-Ojeda, F.J.; Vilchez-Padial, L.M.; Gil, A. Evidence of the anti-inflammatory effects of probiotics and synbiotics in intestinal chronic diseases. Nutrients 2017, 9, 555. [CrossRef] [PubMed]
16. Di Nardo, G.; Oliva, S.; Menichella, A.; Pistelli, R.; De Biase, R.V.; Patriarchi, F.; Cucchiara, S.; Stronati, L. Lactobacillus reuteri ATCC55730 in cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 2014, 58, 81–86. [CrossRef] [PubMed]
17. Bellemare, S.; Hartling, L.; Wiebe, N.; Russell, K.; Craig, W.R.; McConnell, D.; Klassen, T.P. Oral rehydration versus intravenous therapy for treating dehydration due to gastroenteritis in children: A meta-analysis of randomised controlled trials. BMC Med. 2004, 2, 11. [CrossRef] [PubMed]
18. Blum, L.S.; Oria, P.A.; Olson, C.K.; Breiman, R.F.; Ram, P.K. Examining the use of oral rehydration salts and other oral rehydration therapy for childhood diarrhea in Kenya. Am. J. Trop. Med. Hyg. 2011, 85, 1126–1233. [CrossRef] [PubMed]
19. Desjeux, J.F.; Briend, A.; Butzner, J.D. Oral rehydration solution in the year 2000: Pathophysiology, efficacy and effectiveness. Bailliere’s Clin. Gastroenterol. 1997, 11, 509–527. [CrossRef]
20. Hill, C.; Guarner, F.; Reid, G.; Gibson, G.R.; Merenstein, D.J.; Pot, B.; Morelli, L.; Canani, R.B.; Flint, H.J.; Salminen, S.; et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014, 11, 506–514. [CrossRef] [PubMed]
21. Plaza-Díaz, J.; Fernandez-Caballero, J.Á.; Chueca, N.; Garcia, F.; Gómez-Llorente, C.; Sáez-Lara, M.J.; Fontana, L.; Gil, A. Pyrosequencing analysis reveals changes in intestinal microbiota of healthy adults who received a daily dose of immunomodulatory probiotic strains. Nutrients 2015, 7, 3999–4015. [CrossRef] [PubMed]
22. Plaza-Díaz, J.; Robles-Sánchez, C.; Abadía-Molina, F.; Morón-Calvente, V.; Sáez-Lara, M.J.; Ruiz-Bravo, A.; Jiménez-Valera, M.; Gil, A.; Gómez-Llorente, C.; Fontana, L. Adamdec1, Ednrb and Ptgs1/Cox1, inflammation genes upregulated in the intestinal mucosa of obese rats, are downregulated by three probiotic strains. Sci. Rep. 2017, 7, 1939. [CrossRef] [PubMed]
23. Fontana, L.; Bermudez-Brito, M.; Plaza-Diaz, J.; Muñoz-Quezada, S.; Gil, A. Sources, isolation, characterisation and evaluation of probiotics. Br. J. Nutr. 2013, 109, 35–50. [CrossRef] [PubMed]
24. Szajewska, H.; Guarino, A.; Hojsak, I.; Indrio, F.; Kolacek, S.; Shamir, R.; Vandenplas, Y.; Weizman, Z.; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Use of probiotics for management of acute gastroenteritis: A position paper by the ESPGHAN working group for probiotics and prebiotics. J. Pediatr. Gastroenterol. Nutr. 2014, 58, 531–539. [CrossRef] [PubMed]
25. Szajewska, H.; Skórka, A.; Ruszczyński, M.; Gieruszczak-Białek, D. Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children–updated analysis of randomised controlled trials. Aliment. Pharmacol. Ther. 2013, 38, 467–476. [CrossRef] [PubMed]
26. Binns, C.; Lee, M.K. The use of probiotics to prevent diarrhea in young children attending child care centers: A review. J. Exp. Clin. Med. 2010, 2, 269–273. [CrossRef]
27. King, S.; Glanville, J.; Sanders, M.E.; Fitzgerald, A.; Varley, D. Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: A systematic review and meta-analysis. Br. J. Nutr. 2014, 112, 41–54. [CrossRef] [PubMed]
28. Liu, S.; Hu, P.; Du, X.; Zhou, T.; Pei, X. Lactobacillus rhamnosus GG supplementation for preventing respiratory infections in children: A meta-analysis of randomized, placebo controlled trials. Indian Pediatr. 2013, 50, 377–381. [CrossRef] [PubMed]
29. Hao, Q.; Dong, B.R.; Wu, T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst. Rev. 2015, 2, CD006895. [CrossRef]
30. Wang, Y.; Li, X.; Ge, T.; Xiao, Y.; Liao, Y.; Cui, Y.; Zhang, Y.; Ho, W.; Yu, G.; Zhang, T. Probiotics for prevention and treatment of respiratory tract infections in children: A systematic review and meta-analysis of randomized controlled trials. Medicine 2016, 95, e4509. [CrossRef] [PubMed]
31. Williams, N.T. Probiotics. Am. J. Health Syst. Pharm. 2010, 67, 449–458. [CrossRef] [PubMed]
32. Bermudez-Brito, M.; Plaza-Díaz, J.; Muñoz-Quezada, S.; Gómez-Llorente, C.; Gil, A. Probiotic mechanisms of action. Ann. Nutr. Metab. 2012, 61, 160–174. [CrossRef] [PubMed]
33. Muñoz-Quezada, S.; Bermudez-Brito, M.; Chenoll, E.; Genovés, S.; Gomez-Llorente, C.; Plaza-Diaz, J.; Matencio, E.; Bernal, M.J.; Romero, F.; Ramón, D.; et al. Competitive inhibition of three novel bacteria isolated from faeces of breast milk-fed infants against selected enteropathogens. Br. J. Nutr. 2013, 109, S63–S69. [CrossRef] [PubMed]
34. Pineiro, M.; Asp, N.G.; Reid, G.; Macfarlane, S.; Morelli, L.; Brunser, O.; Tuohy, K. FAO Technical meeting on prebiotics. J. Clin. Gastroenterol. 2008, 42, S156–S159. [CrossRef] [PubMed]
35. Sáez-Lara, M.J.; Robles-Sanchez, C.; Ruiz-Ojeda, F.J.; Plaza-Diaz, J.; Gil, A. Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: A review of human clinical trials. Int. J. Mol. Sci. 2016, 17, 928. [CrossRef] [PubMed]
36. Thomas, D.W.; Greer, F.R.; American Academy of Pediatrics Committee on Nutrition; American Academy of Pediatrics Section on Gastroenterology, Hepatology, and Nutrition. Probiotics and prebiotics in pediatrics. Pediatrics 2010, 126, 1217–1231. [CrossRef] [PubMed]
37. Guarner, F.; Khan, A.G.; Garisch, J.; Eliakim, R.; Gangl, A.; Thomson, A.; Krabshuis, J.; Lemair, T.; Kaufmann, P.; de Paula, J.A.; et al. World Gastroenterology Organisation global guidelines. Probiotics and prebiotics October 2011. J. Clin. Gastroenterol. 2012, 46, 468–481. [CrossRef] [PubMed]
38. Marchand, V.; Canadian Paediatric Society, Nutrition and Gastroenterology Committee. Using probiotics in the paediatric population. Paediatr. Child. Health 2012, 17, 575. [CrossRef] [PubMed]
39. Lin, J.S.; Chiu, Y.H.; Lin, N.T.; Chu, C.H.; Huang, K.C.; Liao, K.W.; Peng, K.C. Different effects of probiotic species/strains on infections in preschool children: A double-blind, randomized, controlled study. Vaccine 2009, 27, 1073–1079. [CrossRef] [PubMed]
40. Hojsak, I.; Snovak, N.; Abdović, S.; Szajewska, H.; Misak, Z.; Kolacek, S. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: A randomized, double-blind, placebo-controlled trial. Clin. Nutr. 2010, 29, 312–316. [CrossRef] [PubMed]
41. Hojsak, I.; Abdović, S.; Szajewska, H.; Milosević, M.; Krznarić, Z.; Kolacek, S. Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics 2010, 125. [CrossRef] [PubMed]
42. Sindhu, K.N.; Sowmyanarayanan, T.V.; Paul, A.; Babji, S.; Ajjampur, S.S.; Priyadarshini, S.; Sarkar, R.; Balasubramanian, K.A.; Wanke, C.A.; Ward, H.D.; et al. Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: A randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis. 2014, 58, 1107–1115. [CrossRef] [PubMed]
43. Bruzzese, E.; Fedele, M.C.; Bruzzese, D.; Viscovo, S.; Giannattasio, A.; Mandato, C.; Siani, P.; Guarino, A. Randomised clinical trial: A Lactobacillus GG and micronutrient-containing mixture is effective in reducing nosocomial infections in children, vs. placebo. Aliment. Pharmacol. Ther. 2016, 44, 568–575. [CrossRef] [PubMed]
44. Scalabrin, D.; Harris, C.; Johnston, W.H.; Berseth, C.L. Long-term safety assessment in children who received hydrolyzed protein formulas with Lactobacillus rhamnosus GG: A 5-year follow-up. Eur. J. Pediatr. 2017, 176, 217–224. [CrossRef] [PubMed]
45. Maldonado, J.; Lara-Villoslada, F.; Sierra, S.; Sempere, L.; Gómez, M.; Rodriguez, J.M.; Boza, J.; Xaus, J.; Olivares, M. Safety and tolerance of the human milk probiotic strain Lactobacillus salivarius CECT5713 in 6-month-old children. Nutrition 2010, 26, 1082–1087. [CrossRef] [PubMed]
46. Maldonado, J.; Cañabate, F.; Sempere, L.; Vela, F.; Sánchez, A.R.; Narbona, E.; López-Huertas, E.; Geerlings, A.; Valero, A.D.; Olivares, M.; et al. Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants. J. Pediatr. Gastroenterol. Nutr. 2012, 54, 55–61. [CrossRef] [PubMed]
47. Maldonado-Lobón, J.A.; Gil-Campos, M.; Maldonado, J.; López-Huertas, E.; Flores-Rojas, K.; Valero, A.D.; Rodríguez-Benítez, M.V.; Bañuelos, O.; Lara-Villoslada, F.; Fonollá, J.; et al. Long-term safety of early consumption of Lactobacillus fermentum CECT5716: A 3-year follow-up of a randomized controlled trial. Pharmacol. Res. 2015, 95–96, 12–19. [CrossRef] [PubMed]
48. Agustina, R.; Kok, F.J.; van de Rest, O.; Fahmida, U.; Firmansyah, A.; Lukito, W.; Feskens, E.J.; van den Heuvel, E.G.; Albers, R.; Bovee-Oudenhoven, I.M. Randomized trial of probiotics and calcium on diarrhea and respiratory tract infections in Indonesian children. Pediatrics 2012, 129. [CrossRef] [PubMed]
49. Corsello, G.; Carta, M.; Marinello, R.; Picca, M.; De Marco, G.; Micillo, M.; Ferrara, D.; Vigneri, P.; Cecere, G.; Ferri, P. Preventive effect of cow’s milk fermented with Lactobacillus paracasei CBA L74 on common infectious diseases in children: A multicenter randomized controlled trial. Nutrients 2017, 9, 669. [CrossRef] [PubMed]
50. Merenstein, D.; Murphy, M.; Fokar, A.; Hernandez, R.K.; Park, H.; Nsouli, H.; Sanders, M.E.; Davis, B.A.; Niborski, V.; Tondu, F.; et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: The DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. Eur. J. Clin. Nutr. 2010, 64, 669–677. [CrossRef] [PubMed]
51. Wanke, M.; Szajewska, H. Lack of an effect of Lactobacillus reuteri DSM 17938 in preventing nosocomial diarrhea in children: A randomized, double-blind, placebo-controlled trial. J. Pediatr. 2012. [CrossRef] [PubMed]
52. Prodeus, A.; Niborski, V.; Schrezenmeir, J.; Gorelov, A.; Shcherbina, A.; Rumyantsev, A. Fermented Milk Consumption and Common Infections in Children Attending Day-Care Centers: A Randomized Trial. J. Pediatr. Gastroenterol. Nutr. 2016, 63, 534–543. [CrossRef] [PubMed]
53. İşlek, A.; Sayar, E.; Yılmaz, A.; Baysan, B.Ö.; Mutlu, D.; Artan, R. The role of Bifidobacterium lactis B94 plus inulin in the treatment of acute infectious diarrhea in children. Turk. J. Gastroenterol. 2014, 25, 628–633. [CrossRef] [PubMed]
54. Hojsak, I.; Tokić Pivac, V.; Močić Pavić, A.; Pasini, A.M.; Kolaček, S. Bifidobacterium animalis subsp. lactis fails to prevent common infections in hospitalized children: A randomized, double-blind, placebo-controlled study. Am. J. Clin. Nutr. 2015, 101, 680–684. [CrossRef] [PubMed]
55. Taipale, T.J.; Pienihäkkinen, K.; Isolauri, E.; Jokela, J.T.; Söderling, E.M. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatr. Res. 2016, 79, 65–69. [CrossRef] [PubMed]
56. Goldenberg, J.Z.; Lytvyn, L.; Steurich, J.; Parkin, P.; Mahant, S.; Johnston, B.C. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst. Rev. 2015, 12, CD004827. [CrossRef]
57. Georgieva, M.; Pancheva, R.; Rasheva, N.; Usheva, N.; Ivanova, L.; Koleva, K. Use of the probiotic Lactobacillus reuteri DSM17938 in the prevention of antibiotic-associated infections in hospitalized bulgarian children: A randomized, controlled trial. J. IMAB Annu. Proc. 2015, 21. [CrossRef]
58. Goldenberg, J.Z.; Ma, S.S.; Saxton, J.D.; Martzen, M.R.; Vandvik, P.O.; Thorlund, K.; Guyatt, G.H.; Johnston, B.C. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst. Rev. 2013, 5, CD006095. [CrossRef]
59. Ahmad, K.; Fatemeh, F.; Mehri, N.; Maryam, S. Probiotics for the treatment of pediatric Helicobacter pylori infection: A randomized double blind clinical trial. Iran. J. Pediatr. 2013, 23, 79–84. [PubMed]
60. Namkin, K.; Zardast, M.; Basirinejad, F. Saccharomyces Boulardii in Helicobacter pylori Eradication in children: A randomized trial from Iran. Iran. J. Pediatr. 2016, 26, e3768. [CrossRef] [PubMed]
61. Ustundag, G.H.; Altuntas, H.; Soysal, Y.D.; Kokturk, F. The effects of synbiotic “Bifidobacterium lactis B94 plus inulin” addition on standard triple therapy of Helicobacter pylori eradication in children. Can. J. Gastroenterol. Hepatol. 2017, 2017, 8130596. [CrossRef] [PubMed]
62. Feng, J.R.; Wang, F.; Qiu, X.; McFarland, L.V.; Chen, P.F.; Zhou, R.; Liu, J.; Zhao, Q.; Li, J. Efficacy and safety of probiotic-supplemented triple therapy for eradication of Helicobacter pylori in children: A systematic review and network meta-analysis. Eur. J. Clin. Pharmacol. 2017, 65, 231–238. [CrossRef] [PubMed]
63. Claud, E.C.; Keegan, K.P.; Brulc, J.M.; Lu, L.; Bartels, D.; Glass, E.; Chang, E.B.; Meyer, F.; Antonopoulos, D.A. Bacterial community structure and functional contributions to emergence of health or necrotizing enterocolitis in preterm infants. Microbiome 2013, 1, 1–11. [CrossRef] [PubMed]
64. Alfaleh, K.; Anabrees, J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst. Rev. 2014, 4, CD005496. [CrossRef]
65. Olsen, R.; Greisen, G.; Schrøder, M.; Brok, J. Prophylactic probiotics for preterm infants: A systematic review and meta-analysis of observational studies. Neonatology 2016, 109, 105–112. [CrossRef] [PubMed]
66. Copeland, D.R.; McVay, M.R.; Dassinger, M.S.; Jackson, R.J.; Smith, S.D. Probiotic fortified diet reduces bacterial colonization and translocation in a long-term neonatal rabbit model. J. Pediatr. Surg. 2009, 44, 1061–1064. [CrossRef] [PubMed]
67. Alfaleh, K.; Anabrees, J.; Bassler, D. Probiotics reduce the risk of necrotizing enterocolitis in preterm infants: A meta-analysis. Neonatology 2010, 97, 93–99. [CrossRef] [PubMed]
68. Good, M.; Sodhi, C.P.; Ozolek, J.A.; Buck, R.H.; Goehring, K.C.; Thomas, D.L.; Vikram, A.; Bibby, K.; Morowitz, M.J.; Firek, B.; et al. Lactobacillus rhamnosus HN001 decreases the severity of necrotizing enterocolitis in neonatal mice and preterm piglets: Evidence in mice for a role of TLR9. Am. J. Physiol. Gastrointest. Liver Physiol. 2014, 306, G1021–G1032. [CrossRef] [PubMed]
69. Jones, S.E.; Versalovic, J. Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol. 2009, 9, 35. [CrossRef] [PubMed]
70. Lin, Y.P.; Thibodeaux, C.H.; Pena, J.A.; Ferry, G.D.; Versalovic, J. Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm. Bowel Dis. 2008, 14, 1068–1083. [CrossRef] [PubMed]
71. Liu, Y.; Fatheree, N.Y.; Mangalat, N.; Rhoads, J.M. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299, G1087–G1096. [CrossRef] [PubMed]
72. Liu, Y.; Fatheree, N.Y.; Mangalat, N.; Rhoads, J.M. Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-κB signaling in the intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 302, G608–G617. [CrossRef] [PubMed]
73. McVay, M.R.; Boneti, C.; Habib, C.M.; Keller, J.E.; Kokoska, E.R.; Jackson, R.J.; Smith, S.D. Formula fortified with live probiotic culture reduces pulmonary and gastrointestinal bacterial colonization and translocation in a newborn animal model. J. Pediatr. Surg. 2008, 43, 25–29. [CrossRef] [PubMed]
74. Hoque, S.S.; Faruque, A.S.; Mahalanabis, D.; Hasnat, A. Infectious agents causing acute watery diarrhoea in infants and young children in Bangladesh and their public implications. J. Trop. Pediatr. 1994, 40, 351–354. [CrossRef] [PubMed]
75. Chen, C.C.; Louie, S.; Shi, H.N.; Walker, W.A. Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis. Pediatr. Res. 2005, 58, 1185–1191. [CrossRef] [PubMed]
76. Foye, O.T.; Huang, I.F.; Chiou, C.C.; Walker, W.A.; Shi, H.N. Early administration of probiotic Lactobacillus acidophilus and/or prebiotic inulin attenuates pathogen-mediated intestinal inflammation and Smad 7 cell signaling. FEMS Immunol. Med. Microbiol. 2012, 65, 467–480. [CrossRef] [PubMed]
77. Plaza-Diaz, J.; Gomez-Llorente, C.; Campaña-Martin, L.; Matencio, E.; Ortuño, I.; Martínez-Silla, R.; Gomez-Gallego, C.; Periago, M.J.; Ros, G.; Chenoll, E.; et al. Safety and immunomodulatory effects of three probiotic strains isolated from the feces of breast-fed infants in healthy adults: SETOPROB study. PLoS ONE 2013, 8, e78111. [CrossRef] [PubMed]
78. Li, N.; Russell, W.M.; Douglas-Escobar, M.; Hauser, N.; Lopez, M.; Neu, J. Live and heat-killed Lactobacillus rhamnosus GG (LGG): Effects on pro and anti-inflammatory cyto/chemokines in gastrostomy-fed infant rats. Pediatr. Res. 2009, 66, 203e7. [CrossRef] [PubMed]
79. Guarino, A.; Lo Vecchio, A.; Canani, R.B. Probiotics as prevention and treatment for diarrhea. Curr. Opin. Gastroenterol. 2009, 25, 18–23. [CrossRef] [PubMed]
80. Bloise, E.; Torricelli, M.; Novembri, R.; Borges, L.E.; Carrarelli, P.; Reis, F.M.; Petraglia, F. Heat-killed Lactobacillus rhamnosus GG modulates urocortin and cytokine release in primarytrophoblast cells. Placenta 2010, 31, 867–872. [CrossRef] [PubMed]
81. Cresci, G.A.M.; Mayor, P.C.; Thompson, S.A. Effect of butyrate and Lactobacillus GG on a butyrate receptor and transporter during Campylobacter jejuni exposure. FEMS Microbiol. Lett. 2017, 364. [CrossRef] [PubMed]
82. Huang, I.F.; Lin, I.C.; Liu, P.F.; Cheng, M.F.; Liu, Y.C.; Hsieh, Y.D.; Chen, J.J.; Chen, C.L.; Chang, H.W.; Shu, C.W. Lactobacillus acidophilus attenuates Salmonella-induced intestinal inflammation via TGF-β signaling. BMC Microbiol. 2015, 15, 203. [CrossRef] [PubMed]
83. Rojas, M.A.; Lozano, J.M.; Rojas, M.X.; Rodriguez, V.A.; Rondon, M.A.; Bastidas, J.A.; Perez, L.A.; Rojas, C.; Ovalle, O.; Garcia-Harker, J.E.; et al. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics 2012, 130, e1113–e1120. [CrossRef] [PubMed]
84. Bermudez-Brito, M.; Muñoz-Quezada, S.; Gomez-Llorente, C.; Romero, F.; Gil, A. Lactobacillus rhamnosus and its cell-free culture supernatant differentially modulate inflammatory biomarkers in Escherichia coli-challenged human dendritic cells. Br. J. Nutr. 2014, 111, 1727–1737. [CrossRef] [PubMed]
85. Bermudez-Brito, M.; Muñoz-Quezada, S.; Gomez-Llorente, C.; Matencio, E.; Bernal, M.J.; Romero, F.; Gil, A. Cell-free culture supernatant of Bifidobacterium. breve CNCM I-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation. PLoS ONE 2013, 8, e59370. [CrossRef] [PubMed]
86. Bermudez-Brito, M.; Muñoz-Quezada, S.; Gomez-Llorente, C.; Matencio, E.; Bernal, M.J.; Romero, F.; Gil, A. Human intestinal dendritic cells decrease cytokine release against Salmonella infection in the presence of Lactobacillus paracasei upon TLR activation. PLoS ONE 2012, 7, e43197. [CrossRef] [PubMed]
87. Plaza-Diaz, J.; Gomez-Llorente, C.; Abadia-Molina, F.; Saez-Lara, M.J.; Campaña-Martin, L.; Muñoz-Quezada, S.; Romero, F.; Gil, A.; Fontana, L. Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium. breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on hepatic steatosis in Zucker rats. PLoS ONE 2014, 9, e98401. [CrossRef] [PubMed]
88. Plaza-Díaz, J.; Robles-Sánchez, C.; Abadía-Molina, F.; Sáez-Lara, M.J.; Vilchez-Padial, L.M.; Gil, A.; Gómez-Llorente, C.; Fontana, L. Gene expression profiling in the intestinal mucosa of obese rats administered probiotic bacteria. Sci. Data 2017, 4, 170186. [CrossRef] [PubMed]
89. Gil-Campos, M.; López, M.A.; Rodriguez-Benítez, M.V.; Romero, J.; Roncero, I.; Linares, M.D.; Maldonado, J.; López-Huertas, E.; Berwind, R.; Ritzenthaler, K.L.; et al. Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1–6 months of age: A randomized controlled trial. Pharmacol. Res. 2012, 65, 231–238. [CrossRef] [PubMed]
90. Tsilingiri, K.; Barbosa, T.; Penna, G.; Caprioli, F.; Sonzogni, A.; Viale, G.; Rescigno, M. Probiotic and postbiotic activity in health and disease: Comparison on a novel polarised ex-vivo organ culture model. Gut 2012, 61, 1007–1015. [CrossRef] [PubMed]
91. Buccigrossi, V.; Laudiero, G.; Russo, C.; Miele, E.; Sofia, M.; Monini, M.; Ruggeri, F.M.; Guarino, A. Chloride secretion induced by rotavirus is oxidative stress-dependent and inhibited by Saccharomyces boulardii in human enterocytes. PLoS ONE 2014, 9, e99830. [CrossRef] [PubMed]